story of the week
Safety Study of Palbociclib + Letrozole or Fulvestrant in African American Women With HR+/HER2− MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Contemporary Clinical Trials Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PALINA: A Phase II Safety Study of Palbociclib in Combination With Letrozole or Fulvestrant in African American Women With Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
Contemp Clin Trials Commun 2018 Jun 01;10(xx)190-192, F Lynce, M Saleh, A Shajahan-Haq, C Gallagher, A Dilawari, O Hahn, M Abu-Khalaf, L Cai, P Pohlmann, M Mohebtash, L Kamugisha, C IsaacsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.